本页面由Tiger Trade Technology Pte. Ltd.提供服务

Nasus Pharma Ltd.

2.49
-0.0100-0.40%
盘后2.35-0.1400-5.62%19:44 EDT
成交量:8.54万
成交额:21.14万
市值:2,927.97万
市盈率:-9.46
高:2.54
开:2.46
低:2.35
收:2.50
52周最高:9.99
52周最低:2.29
股本:1,175.89万
流通股本:621.40万
量比:0.48
换手率:1.38%
股息:- -
股息率:- -
每股收益(TTM):-0.2633
每股收益(LYR):-0.2180
净资产收益率:--
总资产收益率:-106.39%
市净率:-6.79
市盈率(LYR):-11.42

数据加载中...

公司资料

公司名字:
Nasus Pharma Ltd.
交易所:
AMEX
成立时间:
2019
员工人数:
2
公司地址:
Yigal Alon 65,Tel Aviv-Yafo,Israel
邮编:
6744317
传真:
- -
简介:
Nasus Pharma Ltd.是一家以色列公司,于2019年5月在以色列注册成立。他们是一家临床阶段的专业制药公司,主要专注于开发治疗紧急医疗状况的鼻内药物。他们正在开发一种独特的PBI技术,拥有专门的产品组合,以应对急性医疗状况和公共健康威胁。

董事

名称
职位
Dan Teleman
Chief Executive Officer, Director
Udi Gilboa
Co-Founder and Executive Chairman of the Board
Dalia Megiddo
Co-Founder, Director, Chief Development Officer and Chief Medical Officer
David Silberman
Director
Isaac Israel
Director
Ronnie Hershman
Director
Sharon Shacham
Director

股东

名称
职位
Dan Teleman
Chief Executive Officer, Director
Eyal Rubin
Executive Vice President and Chief Financial Officer
Dalia Megiddo
Co-Founder, Director, Chief Development Officer and Chief Medical Officer
Galia Temtsin Kryaz
Director of CMC and Product Development
Oren Elmaliach
Director of Finance
Tair Lapidot
Vice President of Research and Development and Clinical Development
Udi Gilboa
Co-Founder and Executive Chairman of the Board